Thursday, August 6


New Delhi: BLK-Max Super Speciality Hospital has launched a comprehensive lung transplant programme, , expanding its advanced thoracic surgery and organ transplantation services for patients with end-stage lung disease.

According to the hospital, the programme will provide comprehensive evaluation, surgical treatment, and long-term post-transplant care for patients with irreversible lung diseases where conventional medical treatment is no longer effective.

It is expected to benefit patients diagnosed with conditions such as interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pulmonary hypertension, bronchiectasis, and other advanced respiratory disorders that significantly impair lung function and quality of life, the hospital added.

The programme will be led by Dr. Pramoj Jindal, Senior Director – Thoracic Surgery & Lung Transplantation, along with a multidisciplinary team comprising thoracic surgeons, pulmonologists, transplant physicians, intensivists, cardiac anaesthetists, rehabilitation specialists, physiotherapists, infectious disease experts, specialised nursing teams and transplant coordinators.

“For patients with end-stage lung disease, there comes a stage where medicines, oxygen therapy, and other supportive treatments are no longer sufficient to maintain lung function. In carefully selected patients, lung transplantation becomes the only definitive treatment capable of improving survival and restoring quality of life,” said Dr. Pramoj Jindal, Senior Director – Thoracic Surgery & Lung Transplantation, BLK-Max Super Speciality Hospital

He added, “The launch of our Comprehensive Lung Transplant Programme brings together specialised surgical expertise, advanced critical care infrastructure, ECMO support and a multidisciplinary team to deliver complete transplant care under one roof.”

  • Published On Aug 6, 2026 at 04:20 PM IST

Join the community of 2M+ industry professionals.

Subscribe to Newsletter to get latest insights & analysis in your inbox.

All about ETHealthworld industry right on your smartphone!




Source link

Share.
Leave A Reply

Exit mobile version